Idiopathic Intracranial Hypertension is Associated with a Higher Burden of Visible Cerebral Perivascular Spaces: The Glymphatic Connection.
Journal
AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
29
03
2021
accepted:
22
08
2021
pubmed:
27
11
2021
medline:
3
3
2022
entrez:
26
11
2021
Statut:
ppublish
Résumé
Research suggests a connection between idiopathic intracranial hypertension and the cerebral glymphatic system. We hypothesized that visible dilated perivascular spaces, possible glymphatic pathways, would be more prevalent in patients with idiopathic intracranial hypertension. This prevalence could provide a biomarker and add evidence to the glymphatic connection in the pathogenesis of idiopathic intracranial hypertension. We evaluated 36 adult (older than 21 years of age) patients with idiopathic intracranial hypertension and 19 controls, 21-69 years of age, who underwent a standardized MR imaging protocol that included high-resolution precontrast T2- and T1-weighted images. All patients had complete neuro-ophthalmic examinations for papilledema. The number of visible perivascular spaces was evaluated using a comprehensive 4-point qualitative rating scale, which graded the number of visible perivascular spaces in the centrum semiovale and basal ganglia; a 2-point scale was used for the midbrain. Readers were blinded to patient diagnoses. Continuous variables were compared using a Student The mean number of visible perivascular spaces overall was greater in the idiopathic intracranial hypertension group than in controls (4.5 [SD, 1.9] versus 2.9 [SD, 1.9], respectively; Idiopathic intracranial hypertension is associated with an increased number of visible intracranial perivascular spaces. This finding provides insight into the pathophysiology of idiopathic intracranial hypertension, suggesting a possible relationship between idiopathic intracranial hypertension and glymphatic dysfunction and providing another useful biomarker for the disease.
Sections du résumé
BACKGROUND AND PURPOSE
Research suggests a connection between idiopathic intracranial hypertension and the cerebral glymphatic system. We hypothesized that visible dilated perivascular spaces, possible glymphatic pathways, would be more prevalent in patients with idiopathic intracranial hypertension. This prevalence could provide a biomarker and add evidence to the glymphatic connection in the pathogenesis of idiopathic intracranial hypertension.
MATERIALS AND METHODS
We evaluated 36 adult (older than 21 years of age) patients with idiopathic intracranial hypertension and 19 controls, 21-69 years of age, who underwent a standardized MR imaging protocol that included high-resolution precontrast T2- and T1-weighted images. All patients had complete neuro-ophthalmic examinations for papilledema. The number of visible perivascular spaces was evaluated using a comprehensive 4-point qualitative rating scale, which graded the number of visible perivascular spaces in the centrum semiovale and basal ganglia; a 2-point scale was used for the midbrain. Readers were blinded to patient diagnoses. Continuous variables were compared using a Student
RESULTS
The mean number of visible perivascular spaces overall was greater in the idiopathic intracranial hypertension group than in controls (4.5 [SD, 1.9] versus 2.9 [SD, 1.9], respectively;
CONCLUSIONS
Idiopathic intracranial hypertension is associated with an increased number of visible intracranial perivascular spaces. This finding provides insight into the pathophysiology of idiopathic intracranial hypertension, suggesting a possible relationship between idiopathic intracranial hypertension and glymphatic dysfunction and providing another useful biomarker for the disease.
Identifiants
pubmed: 34824096
pii: ajnr.A7326
doi: 10.3174/ajnr.A7326
pmc: PMC8805760
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2160-2164Informations de copyright
© 2021 by American Journal of Neuroradiology.
Références
Sci Rep. 2017 Oct 3;7(1):12566
pubmed: 28974720
Cerebrovasc Dis. 2014;37(3):155-63
pubmed: 24503815
Curr Neurol Neurosci Rep. 2020 May 22;20(7):20
pubmed: 32444998
J Neuroophthalmol. 2021 Mar 1;41(1):93-97
pubmed: 33034442
Stroke. 2014 Apr;45(4):1215-21
pubmed: 24503668
Cerebrovasc Dis. 2015;39(3-4):224-31
pubmed: 25823458
Stroke. 2010 Mar;41(3):450-4
pubmed: 20056930
AJNR Am J Neuroradiol. 2017 Mar;38(3):471-477
pubmed: 28104635
Asian J Neurosurg. 2019 Apr-Jun;14(2):440-452
pubmed: 31143260
J Alzheimers Dis. 2018;66(4):1587-1597
pubmed: 30475760
Clin Sci (Lond). 2017 Aug 10;131(17):2257-2274
pubmed: 28798076
Neurology. 2013 Sep 24;81(13):1159-65
pubmed: 23966248
Stroke. 2010 Nov;41(11):2483-90
pubmed: 20864661
Lancet Neurol. 2009 Jul;8(7):643-53
pubmed: 19539236
Neurochem Res. 2015 Dec;40(12):2583-99
pubmed: 25947369
J Transl Med. 2013 May 01;11:107
pubmed: 23635358
Neurology. 2018 Sep 11;91(11):515-522
pubmed: 30201744
Lancet Neurol. 2016 Jan;15(1):78-91
pubmed: 26700907
J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):982-92
pubmed: 26888960
Neuroscientist. 2017 Oct;23(5):454-465
pubmed: 28466758
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
J Neurol. 2020 Nov;267(11):3199-3212
pubmed: 32535680
Lancet Neurol. 2013 May;12(5):483-97
pubmed: 23602162
Stroke. 2009 Jun;40(6):2004-11
pubmed: 19359623
Front Neurol. 2018 Jan 16;8:734
pubmed: 29387036
Neurol Clin. 2010 Aug;28(3):593-617
pubmed: 20637991
Front Aging Neurosci. 2020 Jun 05;12:161
pubmed: 32581771
J Neurol Sci. 2012 Nov 15;322(1-2):25-30
pubmed: 22868088
Int J Stroke. 2015 Apr;10(3):376-81
pubmed: 23692610
PLoS One. 2015 Sep 09;10(9):e0137323
pubmed: 26352265
Neurol Res. 1989 Sep;11(3):160-4
pubmed: 2573851
Curr Probl Diagn Radiol. 2020 May - Jun;49(3):205-214
pubmed: 31056359
Neuron. 2016 Sep 7;91(5):957-973
pubmed: 27608759
Brain. 2007 Aug;130(Pt 8):1988-2003
pubmed: 17322562